148 related articles for article (PubMed ID: 15957166)
1. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.
Jiang WG; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE; Fodstad O
Int J Cancer; 2005 Dec; 117(5):730-7. PubMed ID: 15957166
[TBL] [Abstract][Full Text] [Related]
2. Com-1/p8 acts as a putative tumour suppressor in prostate cancer.
Jiang WG; Davies G; Martin TA; Kynaston H; Mason MD; Fodstad O
Int J Mol Med; 2006 Nov; 18(5):981-6. PubMed ID: 17016631
[TBL] [Abstract][Full Text] [Related]
3. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
4. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
5. Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection.
Jiang WG; Davies G; Fodstad O
Biochem Biophys Res Commun; 2005 Apr; 330(1):253-62. PubMed ID: 15781258
[TBL] [Abstract][Full Text] [Related]
6. The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor.
Davies ML; Parr C; Sanders AJ; Fodstad O; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):75-80. PubMed ID: 20335521
[TBL] [Abstract][Full Text] [Related]
7. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mansel RE
Int J Mol Med; 2006 Apr; 17(4):583-90. PubMed ID: 16525713
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
9. SIRT2: tumour suppressor or tumour promoter in operable breast cancer?
McGlynn LM; Zino S; MacDonald AI; Curle J; Reilly JE; Mohammed ZM; McMillan DC; Mallon E; Payne AP; Edwards J; Shiels PG
Eur J Cancer; 2014 Jan; 50(2):290-301. PubMed ID: 24183459
[TBL] [Abstract][Full Text] [Related]
10. Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.
Du P; Ye L; Yang Y; Jiang WG
Int J Oncol; 2013 Apr; 42(4):1249-56. PubMed ID: 23443904
[TBL] [Abstract][Full Text] [Related]
11. Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer.
Jiang WG; Watkins G; Douglas-Jones A; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Apr; 74(4):235-45. PubMed ID: 16556493
[TBL] [Abstract][Full Text] [Related]
12. Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer.
Jiang WG; Watkins G; Douglas-Jones A; Holmgren L; Mansel RE
BMC Cancer; 2006 Jan; 6():16. PubMed ID: 16430777
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.
Kang H; Watkins G; Parr C; Douglas-Jones A; Mansel RE; Jiang WG
Breast Cancer Res; 2005; 7(4):R402-10. PubMed ID: 15987445
[TBL] [Abstract][Full Text] [Related]
14. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
15. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
Parr C; Gan CH; Watkins G; Jiang WG
Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
17. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
18. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
19. Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.
Das K; Leong DT; Gupta A; Shen L; Putti T; Stein GS; van Wijnen AJ; Salto-Tellez M
Eur J Cancer; 2009 Sep; 45(13):2239-48. PubMed ID: 19632824
[TBL] [Abstract][Full Text] [Related]
20. Tumour suppressor function of MDA-7/IL-24 in human breast cancer.
Patani N; Douglas-Jones A; Mansel R; Jiang W; Mokbel K
Cancer Cell Int; 2010 Aug; 10():29. PubMed ID: 20735832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
